Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3335534
Max Phase: Preclinical
Molecular Formula: C93H109N3O38
Molecular Weight: 1876.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3335534
Max Phase: Preclinical
Molecular Formula: C93H109N3O38
Molecular Weight: 1876.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)OC(=O)[C@H](O[C@H]1O[C@@H](CO)[C@H](OC(=O)c2ccccc2)[C@@H](O[C@@H](Cc2ccccc2)C(=O)O)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O)C(=O)OCCc1cn(CCCCCOC(=O)[C@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@H]2O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](OC(=O)c3ccccc3)[C@H](O[C@H](Cc3ccccc3)C(=O)O)[C@H]2OC(=O)c2ccccc2)C(=O)OC(C)C)nn1
Standard InChI: InChI=1S/C93H109N3O38/c1-49(2)119-88(115)76(133-92-78(129-84(111)57-36-22-11-23-37-57)72(123-60(80(105)106)44-53-28-14-7-15-29-53)70(62(47-97)125-92)127-82(109)55-32-18-9-19-33-55)74(131-90-68(103)66(101)64(99)51(5)121-90)86(113)117-42-27-13-26-41-96-46-59(94-95-96)40-43-118-87(114)75(132-91-69(104)67(102)65(100)52(6)122-91)77(89(116)120-50(3)4)134-93-79(130-85(112)58-38-24-12-25-39-58)73(124-61(81(107)108)45-54-30-16-8-17-31-54)71(63(48-98)126-93)128-83(110)56-34-20-10-21-35-56/h7-12,14-25,28-39,46,49-52,60-79,90-93,97-104H,13,26-27,40-45,47-48H2,1-6H3,(H,105,106)(H,107,108)/t51-,52-,60+,61-,62+,63-,64+,65+,66+,67+,68+,69-,70-,71-,72-,73+,74+,75+,76+,77+,78+,79+,90-,91+,92-,93+/m0/s1
Standard InChI Key: OHTWADSLZOFJRO-JGOGBLJPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1876.88 | Molecular Weight (Monoisotopic): 1875.6689 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Calosso M, Tambutet G, Charpentier D, St-Pierre G, Vaillancourt M, Bencheqroun M, Gratton JP, Prévost M, Guindon Y.. (2014) Acyclic tethers mimicking subunits of polysaccharide ligands: selectin antagonists., 5 (9): [PMID:25221666] [10.1021/ml500266x] |
Source(1):